Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 1977-01-01 (49 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARANGE-SILVANGE (57535), Moselle
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE JAILLY : revenue, balance sheet and financial ratios
PHARMACIE DE JAILLY is a French company
founded 49 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARANGE-SILVANGE (57535),
this company of category PME
shows in 2020 a net income positive of 278 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE JAILLY (SIREN 311021141)
Indicator
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
277 772 €
276 092 €
215 433 €
144 205 €
106 172 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2020, PHARMACIE DE JAILLY generates positive net income of 278 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2020: 106 k€ -> 278 k€.
Net income (2020)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
277 772 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 27%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2020)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
27.469%
Financial autonomy (2020)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
55.006%
Asset age ratio (2020)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
Debt ratio
40.893
24.037
17.922
None
27.469
Financial autonomy
47.277
48.962
52.168
0.0
55.006
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
27.472020
2018
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Excellent
In 2020, the debt ratio of PHARMACIE DE JAILLY (27.47) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
55.01%2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Good
In 2020, the financial autonomy of PHARMACIE DE JAILLY (55.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 243.63. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2020)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
243.632
Liquidity indicators evolution PHARMACIE DE JAILLY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
Liquidity ratio
188.185
154.854
178.303
192.766
243.632
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
243.632020
2018
2019
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Good+16 pts over 3 years
In 2020, the liquidity ratio of PHARMACIE DE JAILLY (243.63) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE JAILLY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 180 transactions of similar company sales
in 2020,
the value of PHARMACIE DE JAILLY is estimated at
3 925 656 €
(range 2 617 572€ - 5 296 770€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2020
180 transactions
2617k€3925k€5296k€
3 925 656 €Range: 2 617 572€ - 5 296 770€
NAF 5 année 2020
Valuation method used
Net Income Multiple
277 772 €
×
14.1x
=3 925 657 €
Range: 2 617 573€ - 5 296 771€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE JAILLY with other companies in the same sector:
Frequently asked questions about PHARMACIE DE JAILLY
What is the revenue of PHARMACIE DE JAILLY ?
The revenue of PHARMACIE DE JAILLY is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE JAILLY profitable?
Yes, PHARMACIE DE JAILLY generated a net profit of 278 k€ in 2020.
Where is the headquarters of PHARMACIE DE JAILLY ?
The headquarters of PHARMACIE DE JAILLY is located in MARANGE-SILVANGE (57535), in the department Moselle.
Where to find the tax return of PHARMACIE DE JAILLY ?
The tax return of PHARMACIE DE JAILLY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE JAILLY operate?
PHARMACIE DE JAILLY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart